Cross-Sectional Study of Q Fever Seroprevalence among Blood Donors, Israel, 2021

Nesrin Ghanem-Zoubi,Yafit Atiya-Nasagi,Evgeniy Stoyanov,Moran Szwarcwort,Basel Darawsha,Mical Paul,Eilat Shinar
DOI: https://doi.org/10.3201/eid3005.230645
IF: 16.126
2024-04-27
Emerging Infectious Diseases
Abstract:We evaluated Q fever prevalence in blood donors and assessed the epidemiologic features of the disease in Israel in 2021. We tested serum samples for Coxeilla burnetii phase I and II IgG using immunofluorescent assay, defining a result of > 200 as seropositive. We compared geographic and demographic data. We included 1,473 participants; 188 (12.7%) were seropositive. The calculated sex- and age-adjusted national seroprevalence was 13.9% (95% CI 12.2%–15.7%). Male sex and age were independently associated with seropositivity (odds ratio [OR] 1.6, 95% CI 1.1–2.2; p = 0.005 for male sex; OR 1.2, 95% CI 1.01–1.03; p<0.001 for age). Residence in the coastal plain was independently associated with seropositivity for Q fever (OR 1.6, 95% CI 1.2–2.3; p<0.001); residence in rural and farming regions was not. Q fever is highly prevalent in Israel. The unexpected spatial distribution in the nonrural coastal plain suggests an unrecognized mode of transmission.
immunology,infectious diseases
What problem does this paper attempt to address?